New members include rheumatology state societies, specialty partners in gastroenterology and patient-facing organizations representing digestive and inflammatory diseases. The ACR and coalition partners are strategizing additional steps to ensure practices receive adequate reimbursement for biosimilars.
The ACR/CHEST ILD Guidelines in Practice, a video
In collaboration with the American College of Chest Physicians, the ACR released two new comprehensive guidelines aimed at improving the screening, monitoring, and treatment of patients with interstitial lung disease (ILD) secondary to systemic autoimmune rheumatic diseases (SARDs). Recently, Sindhu R. Johnson, MD, PhD, professor of medicine at the University of Toronto, Canada, director of the Toronto Scleroderma Program and principal investigator for the guideline, and Elana J. Bernstein, MD, MSc, Florence Irving associate professor of medicine in the Division of Rheumatology at Columbia University, New York City, and co-first author, presented a webinar to talk about how the guidelines were developed and present some of the recommendations and their rationale: Watch the recording now!
Urge Your Lawmakers to Support Critical Medicare Payment Reform
The recently introduced Physician Fee Stabilization Act (S. 4935) would raise the budget neutrality threshold from $20 million to $53 million and help alleviate the annual uncertainty providers face surrounding Medicare reimbursement rates.
ACR Leads Coalition Effort Opposing UHC Policy Change on G2211
In July, UHC announced it would discontinue reimbursement for G2211 for commercial plans as of Sept. 1. The ACR led a multispecialty sign-on letter urging the payer to reconsider its decision to help ensure clinicians can maintain the additional work needed to manage complex and chronic diseases.

Helping Patients with SLE Thrive
Dr. Laurent Arnaud highlighted the latest information on systemic lupus erythematosus (SLE), including genetics, technology, treat to target, and promising findings for pulse therapy in his session at EULAR 2024.

What’s New in Polymyalgia Rheumatica?
Should all patients with polymyalgia rheumatica (PMR) have a vascular ultrasound assessment? What treatments are the safest and most efficacious for patients with PMR? Frank Buttgereit, MD, answered these questions and highlighted the latest research on PMR in this session at EULAR 2024.

Coagulation Education: Treatment Options for Antiphospholipid Syndrome
Dr. Maria Tektonidou discussed the latest recommendations for the treatment of patients with antiphospholipid syndrome (APS), including obstetric and thrombotic subtypes.

The High Stakes of Brain, Ear, Eye Syndromes
Experts detailed the diagnosis and treatment of two patients with Susac syndrome, a brain, ear, eye syndrome. They also provided insights into the complexities of these conditions, why they are difficult to diagnose and key points for practicing rheumatologists.

The Truth About Remote Care
Long wait times for appointments, the rheumatologist shortage in rural areas—does telehealth solve some aspects of access to care for rheumatology patients? Three experts highlighted the data on remote care, unveiling surprising truths and misconceptions.
Summary of Notable Provisions in CY 2025 Medicare PFS Proposed Rule
The ACR will provide comments on several provisions related to Medicare physician payment and the Quality Payment Program.
The ACR’s Top Legislative Priority: Reforming Medicare Reimbursement
The ACR is encouraged that lawmakers are discussing Medicare physician payment reform and continues to work to educate lawmakers about the importance of both short- and long-term policy solutions. Support grassroots efforts by messaging your lawmakers today.
- « Previous Page
- 1
- …
- 14
- 15
- 16
- 17
- 18
- …
- 244
- Next Page »